Bottom line
IBBQ vs FBDIX: the short answer
IBBQ (Invesco Nasdaq Biotechnology ETF) and FBDIX (Franklin Biotechnology Discovery Fund) are quite different portfolios: only about 38% of their top holdings (by weight) are shared.
But IBBQ is far broader, holding 261 positions to 126 for FBDIX, so beyond the top names it adds exposure FBDIX doesn't have.
IBBQ is cheaper at 0.19% vs 1.01% — a difference of $82 a year per $10,000 invested.
Over one year, FBDIX returned +43.9% vs −0.6% for IBBQ (reporting dates differ).
FBDIX has a front-end sales load of up to 5.5%; the other does not.
Updated Nov 19, 2026
IBBQ vs FBDIX side by side
| IBBQ | FBDIX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | Invesco | Franklin Templeton |
| Category | Technology Sector | Technology Sector |
| Expense ratio | 0.19% | 1.01% |
| Annual cost per $10k | $19 | $101 |
| 10-yr cost on $10k (prospectus) | $242 | $1,728 |
| Max front load | None | 5.5% |
| 12b-1 fee | — | 0.25% |
| 1-yr return | −0.6% | +43.9% |
| 5-yr return (annualized) | — | +5.0% |
| 10-yr return (annualized) | — | +6.4% |
| Best quarter | +12.0% | +29.5% |
| Worst quarter | −11.7% | −24.5% |
| Net assets (fund) | $67.4M | $1.2B |
| Number of holdings | 261 | 126 |
| Portfolio turnover | 17% | 38% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | IBBQ | FBDIX | Difference |
|---|---|---|---|
| 2024 | −0.6% | +4.0% | −4.6% |
| 2023 | +4.5% | +18.4% | −13.9% |
| 2022 | −10.2% | −12.7% | +2.4% |
Source: Fund prospectus bar charts
Holdings overlap
10 of IBBQ's top 25 holdings also appear in FBDIX's top 25.
| Holding | IBBQ | FBDIX |
|---|---|---|
| Gilead Sciences, Inc. | 7.39% | 3.86% |
| Vertex Pharmaceuticals Inc. | 7.38% | 3.54% |
| Amgen Inc. | 7.10% | 4.39% |
| Regeneron Pharmaceuticals, Inc. | 5.08% | 3.77% |
| Revolution Medicines, Inc. | 2.48% | 3.01% |
| argenx SE | 1.89% | 3.62% |
| Insmed Inc. | 1.83% | 1.99% |
| Guardant Health, Inc. | 1.35% | 2.76% |
| Neurocrine Biosciences, Inc. | 1.26% | 1.82% |
| BridgeBio Pharma, Inc. | 1.02% | 1.67% |
Source: SEC Form N-PORT
IBBQ top 10
- Invesco Private Prime Fund — 14.20%
- Gilead Sciences, Inc. — 7.39%
- Vertex Pharmaceuticals Inc. — 7.38%
- Amgen Inc. — 7.10%
- Invesco Private Government Fund — 5.48%
- Regeneron Pharmaceuticals, Inc. — 5.08%
- Alnylam Pharmaceuticals, Inc. — 3.19%
- Revolution Medicines, Inc. — 2.48%
- Biogen Inc. — 2.29%
- Illumina, Inc. — 1.98%
FBDIX top 10
- Jazz Pharmaceuticals plc — 5.66%
- Amgen, Inc. — 4.39%
- Gilead Sciences, Inc. — 3.86%
- Regeneron Pharmaceuticals, Inc. — 3.77%
- Argenx SE — 3.62%
- Vertex Pharmaceuticals, Inc. — 3.54%
- Franklin Institutional U.S. Government Money Market Fund — 3.18%
- Revolution Medicines, Inc. — 3.01%
- Guardant Health, Inc. — 2.76%
- Ascendis Pharma A/S — 2.56%
FAQ
What is the difference between IBBQ and FBDIX?
Which is cheaper, IBBQ or FBDIX?
Should I own both IBBQ and FBDIX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.